Woodwards

Chennai, India Founded: 1928 • Age: 98 yrs Listed
Gripe water for infant digestive relief and related baby care services in India.
Request Access
Report Incorrect Data
Page last updated

About Woodwards

Woodwards is a publicly listed company based in Chennai (India) founded in 1928. Gripe water for infant digestive relief and related baby care services in India. The company has 559 employees. Its Indian entity Ttk Healthcare Limited reported revenue of ₹961 Cr. Woodwards offers products and services including Gripe Water and Baby Care Advice. Its focus areas include Health and Wellness, Consumer Goods, Over-the-Counter Remedies and Natural Ingredients.

Company details

Woodwards Gripe Water has been utilized by mothers globally for over 170 years as a remedy for infant discomfort. It is composed of Dill seed oil and Sarjikakshara, which are known to offer symptomatic relief from stomach pain caused by gas, acidity, and indigestion in babies and children. The product is distributed through TTK Healthcare Limited and is accessible via online platforms, with additional resources like FAQs and blogs provided to support parental knowledge on baby care. Information on its safety and usage is drawn from historical application and shared experiences, ensuring it serves as a reliable option for digestive issues.

  • Headquarters Chennai, India
  • Employees 559
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website woodwards.in
  • Social X Facebook Instagram YouTube
  • Legal Name Ttk Healthcare Limited
  • Date of Incorporation 21 May, 1958
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Alternative Medicine Products
Healthcare → Gastroenterology
Key Metrics
  • Market Cap
    ₹1,317 Cr

    TTKHLTCARE · NSE

  • Share Price
    ₹927.55

    -0.45% today

  • Revenue
    ₹889 Cr

    FY 2025-26 · +7.6% YoY

  • EBITDA
    ₹22.10 Cr

    Margin 2.5%

  • Net Profit
    ₹68.68 Cr

    FY 2025-26 · -3.5% YoY

  • P/E (TTM)
    17.8x

    P/B 1.0x

  • ROE
    6.0%

    ROCE 7.7%

  • Debt / Equity
    0.02

    Interest cover 22.0x

  • Employee Count
    559

Products & Services of Woodwards

Woodwards offers a comprehensive portfolio of products and services, including Gripe Water and Baby Care Advice.

Gripe Water
Baby Health Products

Symptomatic relief is provided for stomach pain in infants and children due to gas, acidity, and indigestion through the use of natural ingredients like Dill seed oil and Sarjikakshara.

Baby Care Advice
Advisory Services

Guidance on baby health is made available through blogs and FAQs, covering topics such as colic, acid reflux, and general infant care based on shared experiences and tips.

Apps and channels of Woodwards

its YouTube channel Woodward's Gripe Water has 13.9K subscribers and 30 videos.

Woodward's Gripe Water
YouTube 13.9K subscribers 30 videos Science & Technology
Open channel

Videos from Woodwards

The most watched videos on Woodwards's YouTube channel, Woodward's Gripe Water (13.9K subscribers). Click a video to play it here.

New Generation Moms Trust Woodward’s | Gripe Water for Baby's Tummy Relief | Tamil
438.5K views
Happy Mother's Day 2024| Woodward's Gripe Water | For New Generation Mothers
301.2K views
Woodward's Gripe Water | A Tribute to Single Dads | Happy Father’s Day 2024
208.6K views
Woodward’s Gripe Water – Trusted by mother’s for 170+ Years
203.5K views

More on Woodward's Gripe Water.

Board of directors of Ttk Healthcare Limited (Woodwards)

Ttk Healthcare Limited is the primary company behind Woodwards. The board of Ttk Healthcare Limited currently have 10 directors; the longest-serving is Rajiv Tulshan, appointed in 1984. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajiv Tulshan
DIN 00009876
Director30 Nov 198441 yrs 11 moTtk Healthcare Limited
Raghunathan Thiruvallur Thattai
DIN 00043455
Whole-time director31 Dec 199827 yrs 10 moTtk Healthcare Limited
Krishnamurthy Shankaran
DIN 00043205
Director09 Oct 200026 yrsTtk Healthcare Limited
Subramaniam Kalyanaraman
DIN 00119541
Managing Director22 Aug 201412 yrs 2 moTtk Healthcare Limited
Vijayaraghavachari Ranganathan
DIN 00550121
Director01 Jun 20197 yrs 5 moTtk Healthcare Limited
Mukund Thiruvallur Thattai
DIN 07193370
Director09 Sep 20224 yrs 2 moTtk Healthcare Limited
Murali Neelakantan
DIN 02453014
Director22 Aug 20242 yrs 2 moTtk Healthcare Limited
Hastha Shivaramakrishnan
DIN 00391864
Director16 Oct 20242 yrsTtk Healthcare Limited
Subashree Anantkrishnan
DIN 10898908
Director24 Jan 20251 yr 9 moTtk Healthcare Limited
Vaithianathan Sundaresan
DIN 11435475
Director22 Dec 202510 moTtk Healthcare Limited

IPO & Listings of Woodwards

Woodwards is a publicly listed company on the NSE with ticker symbol TTKHLTCARE in India, operating in the Diversified sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: TTKHLTCARE
  • Listed entityTtk Healthcare Limited
  • Exchange sectorDiversified

Financials of Woodwards

Exchange-reported figures of Ttk Healthcare Limited, the listed company behind Woodwards (NSE: TTKHLTCARE).

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹889 Cr
+7.6% YoY
EBITDA
₹22.10 Cr
-36.5% YoY
Profit After Tax
₹68.68 Cr
-3.5% YoY
Net Worth
₹1,115 Cr
+4.7% YoY
Total Assets
₹1,145 Cr
+4.8% YoY
Total Debt
₹24.37 Cr
+0.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue889826753725599476646
Revenue growth+7.6%+9.7%+3.8%+21.0%+25.9%-26.3%-
EBITDA22.1034.8237.3231.3521.8319.3228.30
EBITDA margin+2.5%+4.2%+5.0%+4.3%+3.6%+4.1%+4.4%
Profit before tax82.5610884.1165747.9132.2819.43
Net profit68.6871.2062.8564039.4940.3112.35
Net profit margin+7.7%+8.6%+8.4%+88.2%+6.6%+8.5%+1.9%
EPS (₹)46.4857.7944.47452.7229.4332.878.72
Balance sheet
Total assets1,1451,0931,027985359324288
Net worth1,1151,0651,001953330295249
Total debt24.3724.2222.8127.3322.2119.1529.84
Cash & bank633786775847274228132
Net working capital1,034915898881249204155
Cash flow
Cash from operations(21.15)(3.98)(4.94)(24.81)45.0096.4219.84
Cash from investing51.5820.1028.4931.69(29.56)(77.24)(13.30)
Cash from financing(17.56)(18.08)(21.91)(12.43)(10.13)(17.16)(10.17)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue233258218209204226190205
Revenue growth (YoY)+14.6%+13.8%+14.5%+2.2%+2.6%+8.9%--
Other income26716.7921.2717.4319.0117.9418.6917.84
Total expenses230243207210198224184197
EBITDA3.7414.7411.02(0.44)5.342.686.147.69
EBITDA margin+1.6%+5.7%+5.1%-0.2%+2.6%+1.2%+3.2%+3.8%
Depreciation2.162.142.142.222.212.192.172.11
Interest0.590.530.640.680.840.770.900.82
Profit before tax26828.8629.5114.0921.3017.6621.7622.60
Tax44.967.587.763.550.914.655.615.86

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue233258218209204226190205
Revenue growth (YoY)+14.6%+13.8%+14.5%+2.2%+2.6%+8.9%--
Other income26716.7921.2717.4319.0117.9418.6917.84
Total expenses230243207210198224184197
EBITDA3.7414.7411.02(0.44)5.342.686.147.69
EBITDA margin+1.6%+5.7%+5.1%-0.2%+2.6%+1.2%+3.2%+3.8%
Depreciation2.162.142.142.222.212.192.172.11
Interest0.590.530.640.680.840.770.900.82
Profit before tax26828.8629.5114.0921.3017.6621.7622.60
Tax44.967.587.763.550.914.655.615.86
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue889826753725599476646
Revenue growth+7.6%+9.7%+3.8%+21.0%+25.9%-26.3%-
Other income72.1585.1662.6164341.9027.698.78
Total expenses866791715694577457617
Employee cost16515113312310393.70144
EBITDA22.1034.8237.3231.3521.8319.3228.30
EBITDA margin+2.5%+4.2%+5.0%+4.3%+3.6%+4.1%+4.4%
Depreciation8.768.3313.0612.8112.5813.0214.38
Interest2.933.322.765.243.241.713.27
Profit before tax82.5610884.1165747.9132.2819.43
Tax16.8826.6721.2816.976.33(14.16)7.11
Net profit68.6871.2062.8564039.4940.3112.35
Net profit margin+7.7%+8.6%+8.4%+88.2%+6.6%+8.5%+1.9%
EPS (₹)46.4857.7944.47452.7229.4332.878.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.1314.1314.1314.1314.1314.1314.13
Reserves & surplus1,1011,051987939316281235
Shareholders' funds (net worth)1,1151,0651,001953330295249
Secured loans21.9021.9421.4725.5320.3817.6028.13
Unsecured loans2.472.281.341.801.831.551.71
Total debt24.3724.2222.8127.3322.2119.1529.84
Total liabilities1,1451,0931,027985359324288
Assets
Gross block182183178164165159149
Net block72.6880.9074.8171.1980.2885.3588.64
Capital work in progress1.370.080.792.790.190.458.77
Investments8.6611.2212.5612.8515.1313.178.75
Inventories10910996.9984.5178.9270.3071.64
Sundry debtors11190.5386.4492.1053.5859.7876.77
Cash & bank balances633786775847274228132
Loans & advances36511811942.3042.4917.1017.22
Total current assets1,2181,1041,0771,066448375298
Total current liabilities184188180185200171143
Net working capital1,034915898881249204155
Total assets1,1451,0931,027985359324288
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash9.0110.969.3214.869.557.5311.15
Net cash from operating activities(21.15)(3.98)(4.94)(24.81)45.0096.4219.84
Net cash from investing activities51.5820.1028.4931.69(29.56)(77.24)(13.30)
Net cash from financing activities(17.56)(18.08)(21.91)(12.43)(10.13)(17.16)(10.17)
Net change in cash12.88(1.95)1.64(5.54)5.312.03(3.63)
Closing cash633786775847274228132
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+7.6%+9.7%+3.8%+21.0%+25.9%-26.3%-
EBITDA growth-36.5%-6.7%+19.0%+43.6%+13.0%-31.7%-
PBT growth-23.8%+28.8%-87.2%+1270.7%+48.4%+66.1%-50.5%
Net income growth-3.5%+13.3%-90.2%+1520.3%-2.0%+226.4%-
Revenue CAGR (3Y)+7.0%+11.3%+16.5%+3.9%-1.5%-6.2%+7.0%
EBITDA CAGR (3Y)-11.0%+16.8%+24.5%+3.5%-23.9%-23.1%-9.7%
Profitability & leverage
Net income margin+7.4%+9.9%+8.4%+88.2%+6.9%+9.8%+1.9%
Return on capital employed+7.7%+9.3%+8.7%+10.0%+7.6%+5.4%+8.0%
Return on net worth+6.1%+6.9%+6.5%+100.4%+12.8%+15.1%+5.0%
Debt / equity0.020.020.030.040.070.090.12
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover21.9612.5311.3828.2635.0327.1423.49
Efficiency & per share
Fixed asset turnover4.994.694.524.533.813.194.55
Inventory turnover8.188.038.308.878.036.7110.17
Debtors turnover8.839.338.439.9510.576.978.23
EPS (₹)46.4857.7944.47452.7229.4332.878.72
Dividend per share (₹)10.0010.0010.0010.0010.006.003.00
Book value per share (₹)785.85750.61705.23671.59230.16205.40173.09

Web traffic of Woodwards

The website of Woodwards (woodwards.in) receives about 2.5K visits a month.

  • Monthly visits
    2.5K

    ▲ 26.8% vs previous month

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Woodwards (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Schwabe India
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Healthmug
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Jiva Ayurveda
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Woodwards

TTKHLTCARE: Q2 EBITDA 37M RUPEES VS 53.3M (YOY); Q2 EBITDA MARGIN 1.6% VS 2.62% (YOY)
Exchange Update • 10 days ago
TTKHLTCARE: Q2 SL PBT 197M RUPEES VS 213M (YOY); CO HAS AN EXCEPTIONAL ITEM OF 2.5B RUPEES
Exchange Update • 10 days ago
TTKHLTCARE: Q2 REVENUE 2.33B RUPEES VS 2B (YOY)
Exchange Update • 10 days ago
Wipro Consumer Care bets on digital-first skincare brand with Dermatouch acquisition
Mint • 2 months ago
TTK Healthcare June-Quarter Profit 212.8 Million Rupees
Reuters • 3 months ago
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today - 27 July 2026
Mint • 3 months ago
Wipro Consumer, Murugappa lead race for Double Horse
Mint • 3 months ago
TTK Healthcare Board Approves Sale Of 'Eva' And 'Good Home' Brands
Reuters • 3 months ago
Wipro Consumer Care to acquire TTK HealthCare’s Eva, Good Home brands
VCCircle • 3 months ago
Wipro Consumer Care acquires Good Home, Eva brands from TTK Healthcare for ₹256 cr - The HinduBusinessLine
Thehindubusinessline • 3 months ago
Premium access

Complete news archive for Woodwards

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Woodwards

Woodwards was founded in 1928.

Woodwards is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Woodwards has 559 employees.

The primary company behind Woodwards, Ttk Healthcare Limited, reported revenue of ₹961 Cr for FY 2026, up 8% year on year.

Woodwards Gripe Water has been utilized by mothers globally for over 170 years as a remedy for infant discomfort. It is composed of Dill seed oil and Sarjikakshara, which are known to offer symptomatic relief from stomach pain caused by gas, acidity, and indigestion in babies and children. The product is distributed through TTK Healthcare Limited and is accessible via online platforms, with additional resources like FAQs and blogs provided to support parental knowledge on baby care. Information on its safety and usage is drawn from historical application and shared experiences, ensuring it serves as a reliable option for digestive issues.

Woodwards offers Gripe Water and Baby Care Advice.

Yes, Woodwards is publicly traded on NSE under the ticker symbol TTKHLTCARE.

Woodwards operates through Ttk Healthcare Limited.

The legal entities of Woodwards currently have 12 directors, including Raghunathan Thiruvallur Thattai, Vijayaraghavachari Ranganathan, Subramaniam Kalyanaraman and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available